EKSO
Price
$3.89
Change
+$0.09 (+2.37%)
Updated
Aug 28 closing price
Capitalization
10.16M
MBGNF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Dec 2 closing price
Capitalization
187.11K
Interact to see
Advertisement

EKSO vs MBGNF

Header iconEKSO vs MBGNF Comparison
Open Charts EKSO vs MBGNFBanner chart's image
Ekso Bionics Holdings
Price$3.89
Change+$0.09 (+2.37%)
Volume$25.92K
Capitalization10.16M
MANY BRIGHT IDEAS TECHNOLOGIES
Price$0.01
Change-$0.00 (-0.00%)
Volume$6.3K
Capitalization187.11K
EKSO vs MBGNF Comparison Chart in %
Loading...
EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EKSO vs. MBGNF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKSO is a StrongBuy and MBGNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (EKSO: $3.89 vs. MBGNF: $0.01)
Brand notoriety: EKSO and MBGNF are both not notable
EKSO represents the Pharmaceuticals: Other, while MBGNF is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EKSO: 24% vs. MBGNF: 100%
Market capitalization -- EKSO: $10.16M vs. MBGNF: $187.11K
EKSO [@Pharmaceuticals: Other] is valued at $10.16M. MBGNF’s [@Medical Specialties] market capitalization is $187.11K. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B. The average market capitalization across the [@Medical Specialties] industry is $10.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EKSO’s FA Score shows that 0 FA rating(s) are green whileMBGNF’s FA Score has 0 green FA rating(s).

  • EKSO’s FA Score: 0 green, 5 red.
  • MBGNF’s FA Score: 0 green, 5 red.
According to our system of comparison, EKSO is a better buy in the long-term than MBGNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EKSO’s TA Score shows that 6 TA indicator(s) are bullish.

  • EKSO’s TA Score: 6 bullish, 4 bearish.

Price Growth

EKSO (@Pharmaceuticals: Other) experienced а +16.12% price change this week, while MBGNF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.91%. For the same industry, the average monthly price growth was +4.90%, and the average quarterly price growth was +15.22%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.82%. For the same industry, the average monthly price growth was +6.47%, and the average quarterly price growth was +7.37%.

Industries' Descriptions

@Pharmaceuticals: Other (+3.91% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+0.82% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EKSO($10.2M) has a higher market cap than MBGNF($187K). MBGNF YTD gains are higher at: 0.000 vs. EKSO (-57.486). MBGNF has higher annual earnings (EBITDA): -53.72K vs. EKSO (-9.25M). EKSO has more cash in the bank: 5.24M vs. MBGNF (217). EKSO has higher revenues than MBGNF: EKSO (14.7M) vs MBGNF (0).
EKSOMBGNFEKSO / MBGNF
Capitalization10.2M187K5,455%
EBITDA-9.25M-53.72K17,222%
Gain YTD-57.4860.000-
P/E RatioN/AN/A-
Revenue14.7M0-
Total Cash5.24M2172,415,668%
Total Debt5.39MN/A-
FUNDAMENTALS RATINGS
EKSO vs MBGNF: Fundamental Ratings
EKSO
MBGNF
OUTLOOK RATING
1..100
1425
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9271
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EKSO's Valuation (44) in the Medical Specialties industry is somewhat better than the same rating for MBGNF (100) in the null industry. This means that EKSO’s stock grew somewhat faster than MBGNF’s over the last 12 months.

EKSO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MBGNF (100) in the null industry. This means that EKSO’s stock grew similarly to MBGNF’s over the last 12 months.

EKSO's SMR Rating (100) in the Medical Specialties industry is in the same range as MBGNF (100) in the null industry. This means that EKSO’s stock grew similarly to MBGNF’s over the last 12 months.

MBGNF's Price Growth Rating (71) in the null industry is in the same range as EKSO (92) in the Medical Specialties industry. This means that MBGNF’s stock grew similarly to EKSO’s over the last 12 months.

MBGNF's P/E Growth Rating (100) in the null industry is in the same range as EKSO (100) in the Medical Specialties industry. This means that MBGNF’s stock grew similarly to EKSO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EKSOMBGNF
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
12%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
11%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KARO52.530.91
+1.77%
Karooooo Ltd
ICL6.540.09
+1.40%
ICL Group Ltd
MLP17.420.17
+0.99%
Maui Land & Pineapple Co
ATMVU12.20N/A
N/A
AlphaVest Acquisition Corp
BDL29.50-0.13
-0.44%
Flanigan's Enterprises

EKSO and

Correlation & Price change

A.I.dvisor tells us that EKSO and MBOT have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKSO and MBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKSO
1D Price
Change %
EKSO100%
+2.37%
MBOT - EKSO
27%
Poorly correlated
-1.72%
ATEC - EKSO
25%
Poorly correlated
-0.93%
RVP - EKSO
24%
Poorly correlated
+1.20%
NMTC - EKSO
24%
Poorly correlated
-1.48%
TMDX - EKSO
24%
Poorly correlated
-0.56%
More

MBGNF and

Correlation & Price change

A.I.dvisor tells us that MBGNF and NVYTF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBGNF and NVYTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBGNF
1D Price
Change %
MBGNF100%
N/A
NVYTF - MBGNF
28%
Poorly correlated
N/A
RYLPF - MBGNF
24%
Poorly correlated
+1.59%
AVHHL - MBGNF
24%
Poorly correlated
N/A
NVNO - MBGNF
21%
Poorly correlated
-3.75%
EKSO - MBGNF
21%
Poorly correlated
+2.37%
More